|
Apr 16
|
Imugene partners with Kincell Bio; selling cell therapy manufacturing facility for $6 million
|
|
Apr 15
|
Bile Tract Cancer expansion study opens following clearance of Imugene’s MAST trial high dose cohort
|
|
Apr 15
|
Imugene opens enrolment for Bile Tract Cancer expansion study
|
|
Feb 22
|
Imugene Highlights Recent Achievements and Looks Ahead to Key Upcoming Immuno-oncology Catalysts
|
|
Dec 6
|
Imugene to commence new phase 2 PD1-Vaxx bowel cancer trial
|
|
Nov 28
|
Imugene thrilled as VAXINIA granted FDA Fast Track designation
|
|
Nov 6
|
Imugene sees positive early signals in Phase 1 VAXINIA study
|